Physician profile
Howard A Stone
NPI 1164590154
$1,812.44
in general payments reported to CMS, 2019-2025
14 companies · $76.34 in 2025
The $76.34 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $361 · 2021: $206 · 2022: $234 · 2023: $177 · 2024: $320 · 2025: $76.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $784.51 | 2019-2025 | Alphavent, Ortholoc 3di, Augment Injectable |
| Osteomed LLC | $216.52 | 2019-2022 | |
| Wright Medical Technology, INC. | $160.86 | 2019 | |
| Medartis INC. | $118.33 | 2023 | Aptus |
| Amniox Medical, INC. | $112.57 | 2019-2020 | |
| Accufix Surgical INC. | $107.53 | 2021 | |
| Smith+Nephew, INC. | $81.56 | 2020-2021 | |
| Fusion Orthopedics USA, LLC | $80.29 | 2024-2025 | |
| Kerecis Limited | $42.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Janssen Pharmaceuticals, INC | $25.61 | 2019 | |
| Arthrosurface Incorporated | $23.61 | 2019 | |
| Integra Lifesciences Corporation | $20.93 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $19.49 | 2023 | Osteomed |
| Horizon Therapeutics Plc | $17.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.